244 related articles for article (PubMed ID: 29644867)
21. Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7.
Gandhi R; Khatri N; Baradia D; Vhora I; Misra A
Drug Deliv; 2016 May; 23(4):1152-62. PubMed ID: 25586675
[TBL] [Abstract][Full Text] [Related]
22. Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
Sine J; Urban C; Thayer D; Charron H; Valim N; Tata DB; Schiff R; Blumenthal R; Joshi A; Puri A
Int J Nanomedicine; 2015; 10():125-45. PubMed ID: 25565809
[TBL] [Abstract][Full Text] [Related]
23. Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.
Awad NS; Paul V; Mahmoud MS; Al Sawaftah NM; Kawak PS; Al Sayah MH; Husseini GA
ACS Biomater Sci Eng; 2020 Jan; 6(1):48-57. PubMed ID: 33463192
[TBL] [Abstract][Full Text] [Related]
24. Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy.
Madan J; Gundala SR; Kasetti Y; Bharatam PV; Aneja R; Katyal A; Jain UK
Anticancer Drugs; 2014 Jul; 25(6):704-16. PubMed ID: 24642711
[TBL] [Abstract][Full Text] [Related]
25. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
[TBL] [Abstract][Full Text] [Related]
26. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
27. Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment.
Jose A; Ninave KM; Karnam S; Venuganti VVK
J Liposome Res; 2019 Jun; 29(2):153-162. PubMed ID: 30022700
[TBL] [Abstract][Full Text] [Related]
28. Low-intensity light-induced drug release from a dual delivery system comprising of a drug loaded liposome and a photosensitive conjugate.
Meerovich I; Nichols MG; Dash AK
J Drug Target; 2020 Jul; 28(6):655-667. PubMed ID: 31886709
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
30. Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake.
Goldenbogen B; Brodersen N; Gramatica A; Loew M; Liebscher J; Herrmann A; Egger H; Budde B; Arbuzova A
Langmuir; 2011 Sep; 27(17):10820-9. PubMed ID: 21819046
[TBL] [Abstract][Full Text] [Related]
31. Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy.
Mohammadi Z; Samadi FY; Rahmani S; Mohammadi Z
Daru; 2020 Dec; 28(2):433-442. PubMed ID: 32656689
[TBL] [Abstract][Full Text] [Related]
32. Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex.
Yin JJ; Shumyak SP; Burgess C; Zhou ZW; He ZX; Zhang XJ; Pan ST; Yang TX; Duan W; Qiu JX; Zhou SF
Int J Nanomedicine; 2015; 10():4717-30. PubMed ID: 26251594
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines.
Banu H; Sethi DK; Edgar A; Sheriff A; Rayees N; Renuka N; Faheem SM; Premkumar K; Vasanthakumar G
J Photochem Photobiol B; 2015 Aug; 149():116-28. PubMed ID: 26057021
[TBL] [Abstract][Full Text] [Related]
34. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
35. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.
AlSawaftah NM; Awad NS; Paul V; Kawak PS; Al-Sayah MH; Husseini GA
Sci Rep; 2021 Jun; 11(1):11589. PubMed ID: 34078930
[TBL] [Abstract][Full Text] [Related]
36. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells.
Kayani Z; Bordbar AK; Firuzi O
Biomed Pharmacother; 2018 Nov; 107():945-956. PubMed ID: 30257407
[TBL] [Abstract][Full Text] [Related]
37. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
Shroff K; Kokkoli E
Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
[TBL] [Abstract][Full Text] [Related]
38. Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes.
Novell A; Al Sabbagh C; Escoffre JM; Gaillard C; Tsapis N; Fattal E; Bouakaz A
Int J Hyperthermia; 2015 Jun; 31(4):349-58. PubMed ID: 25677841
[TBL] [Abstract][Full Text] [Related]
39. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer.
Wang Z; Yu Y; Dai W; Lu J; Cui J; Wu H; Yuan L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Nov; 33(33):8451-60. PubMed ID: 22940213
[TBL] [Abstract][Full Text] [Related]
40. Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes.
Awad NS; Paul V; AlSawaftah NM; Husseini GA
Sci Rep; 2023 Oct; 13(1):16644. PubMed ID: 37789072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
